Manidipine Arrow

Manidipine, the active ingredient in Manidipine Arrow, is a calcium channel blocker presented as an oral tablet for oral use. It treats hypertension in adult patients by lowering elevated blood pressure.

GNH USA supplies Manidipine Arrow as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manidipine is indicated for the management of hypertension, acting on the vascular smooth‑muscle tone to reduce systemic blood pressure.

Hypertension: lowers systolic and diastolic pressure and helps achieve target blood pressure goals in patients with essential hypertension.

Manidipine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate intensity. - Flushing: transient warmth and redness of the skin. - Peripheral edema: swelling of the ankles or feet. - Dizziness or light‑headedness, especially after standing. - Tachycardia: increased heart rate. - Fatigue: general feeling of tiredness.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Myocardial infarction: rare occurrence of heart attack. - Hepatic dysfunction: abnormal liver enzyme elevations. - Allergic reactions: rash, pruritus, or urticaria. - Angioedema: swelling of face, lips, or throat. - Cardiac arrhythmias: irregular heart rhythms.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential risks. - Blood pressure monitoring: check regularly to avoid excessive hypotension. - Hepatic impairment: use with caution and consider dose adjustment. - Concomitant antihypertensives: assess for additive blood‑pressure‑lowering effects. - Elderly patients: start at the lowest effective dose and monitor tolerance. - Severe hypotension: contraindicated in patients with markedly low blood pressure. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Manidipine can interact with several drug classes, influencing its efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase plasma concentrations. - Grapefruit juice: can elevate drug levels and risk of hypotension. - Other potent vasodilators: may cause additive hypotensive effects.

Moderate Interactions (Monitor Closely):\n- Diuretics: may enhance antihypertensive response, requiring dose adjustment. - Beta‑blockers: combined effect on heart rate and blood pressure. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may reduce antihypertensive efficacy. - Calcium supplements: could attenuate vasodilatory action. - Alcohol: may increase dizziness and hypotension.